Literature DB >> 9824210

Localization and expression of the human estrogen receptor beta gene in uterine leiomyomata.

F Pedeutour1, B J Quade, S Weremowicz, P Dal Cin, S Ali, C C Morton.   

Abstract

Estrogens have an important function in the natural history of uterine leiomyomata. The human estrogen receptor beta gene (ESR2) has been identified recently and mapped to 14q22-24, a region frequently rearranged in uterine leiomyomata and other benign tumors, including pulmonary chondroid hamartomas and endometrial polyps. Using fluorescence in situ hybridization and radiation hybrid mapping, we map ESR2 within 14q23-24.1, to a region approximately 2 Mb centromeric to the t(12;14) breakpoint in uterine leiomyomata, between markers D14S63 and WI-7536. Two YAC clones, 948B6 and 741H4, contain ESR2. Using RT-PCR, we show that ESR2 is expressed in uterine leiomyomata and pulmonary chondroid hamartomas as well as in normal myometrium. Lack of a direct relationship between rearrangement of 14q23-24 and ESR2 expression suggests that ESR2 is not involved with HMGIC or HMGIY in t(12;14) or t(6;14). However, because of its relatively close physical distance from the characteristic site of rearrangements in 14q23-24, a role for ESR2 in the pathobiology of these tumors warrants future consideration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9824210     DOI: 10.1002/(sici)1098-2264(199812)23:4<361::aid-gcc12>3.0.co;2-4

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  11 in total

1.  Expression of a mitochondrial progesterone receptor (PR-M) in leiomyomata and association with increased mitochondrial membrane potential.

Authors:  Quanling Feng; John R Crochet; Qunsheng Dai; Phyllis C Leppert; Thomas M Price
Journal:  J Clin Endocrinol Metab       Date:  2014-01-13       Impact factor: 5.958

Review 2.  Literature Review on the Role of Uterine Fibroids in Endometrial Function.

Authors:  Deborah E Ikhena; Serdar E Bulun
Journal:  Reprod Sci       Date:  2017-08-22       Impact factor: 3.060

Review 3.  Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.

Authors:  Arno E Commandeur; Aaron K Styer; Jose M Teixeira
Journal:  Hum Reprod Update       Date:  2015-07-03       Impact factor: 15.610

Review 4.  Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution.

Authors:  Molly B Moravek; Serdar E Bulun
Journal:  Curr Opin Obstet Gynecol       Date:  2015-08       Impact factor: 1.927

5.  Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma.

Authors:  B J Quade; A P Pinto; D R Howard; W A Peters; C P Crum
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

Review 6.  Leiomyomata uteri: hormonal and molecular determinants of growth.

Authors:  Richard Enrique Blake
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

Review 7.  Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.

Authors:  Molly B Moravek; Ping Yin; Masanori Ono; John S Coon; Matthew T Dyson; Antonia Navarro; Erica E Marsh; Debabrata Chakravarti; J Julie Kim; Jian-Jun Wei; Serdar E Bulun
Journal:  Hum Reprod Update       Date:  2014-09-08       Impact factor: 15.610

8.  Stromal fibroblasts from perimenopausal endometrium exhibit a different transcriptome than those from the premenopausal endometrium.

Authors:  David W Erikson; Fatima Barragan; Terhi T Piltonen; Joseph C Chen; Shaina Balayan; Juan C Irwin; Linda C Giudice
Journal:  Biol Reprod       Date:  2017-09-01       Impact factor: 4.285

Review 9.  Etiology and pathogenesis of uterine leiomyomas: a review.

Authors:  Gordon P Flake; Janet Andersen; Darlene Dixon
Journal:  Environ Health Perspect       Date:  2003-06       Impact factor: 9.031

Review 10.  Fertility impairment associated with uterine fibroids - a review of literature.

Authors:  Marek Lisiecki; Maciej Paszkowski; Sławomir Woźniak
Journal:  Prz Menopauzalny       Date:  2017-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.